The Effects of Pelvic Radiotherapy on Cancer Survivors: Symptom Profile, Psychological Morbidity and Quality of Life

Clinical Oncology

Volumn 26, Issue 1, 2014, Pages 10-17

  Adams, E ^a   Boulton, M G ^a   Horne, A ^b   Rose, P W ^c   Durrant, L ^b   Collingwood, M ^b   Oskrochi, R ^a   Davidson, S E ^d   Watson, E K ^a  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Late effects; Long term cancer survivors; Pelvic radiotherapy; Psychological morbidity; Quality of life

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; BLADDER DYSFUNCTION; CANCER RADIOTHERAPY; CANCER SURVIVOR; DIABETES MELLITUS; ENDOMETRIUM CANCER; ENTERITIS; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERTENSION; INTESTINAL DYSMOTILITY; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PELVIC INFLAMMATORY DISEASE; PELVIS RADIOTHERAPY; PELVIS SURGERY; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RADIOTHERAPY; RECTUM CANCER; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEXUAL DYSFUNCTION; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVIX CANCER; VAGINA CANCER; VASCULAR DISEASE;

LATE EFFECTS; LONG-TERM CANCER SURVIVORS; PELVIC RADIOTHERAPY; PSYCHOLOGICAL MORBIDITY; QUALITY OF LIFE;

AGED; FEMALE; HUMANS; MALE; NEOPLASMS; PELVIS; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL RATE; SURVIVORS;

EID: 84890806310     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.08.003     Document Type: Article

References (30)

1. West C.M., Davidson S.E. Measurement tools for gastrointestinal symptoms in radiation oncology. Curr Opin Support Palliat Care 2009, 3(1):36-40.
2. Andreyev H.J. Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol (R Coll Radiol) 2007, 19(10):790-799.
3. Olopade F.A., Norman A., Blake P., et al. Amodified inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy. Br J Cancer 2005, 92(9):1663-1670.
4. Putta S., Andreyev H.J. Faecal incontinence: a late side-effect of pelvic radiotherapy. Clin Oncol (R Coll Radiol) 2005, 17(6):469-477.
5. Vistad I., Cvancarova M., Fossa S.D., et al. Post-radiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?. Int J Radiat Oncol Biol Phys 2008, 71(5):1335-1342.
6. Damast S., Alektiar K.M., Goldfarb S., et al. Sexual functioning among endometrial cancer patients treated with adjuvant high-dose rate intra-vaginal radiation therapy. Int J Radiat Oncol Biol Phys 2013, 84(2):e187-e193.
7. White I.D. The assessment and management of sexual difficulties after treatment of cervical and endometrial malignancies. Clin Oncol (R Coll Radiol) 2008, 20(6):488-496.
8. Routledge J., Burns M., Swindell R., et al. Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int J Radiat Oncol Biol Phys 2003, 56(2):502-510.
9. Anacak Y., Yalman D., Ozsaran Z., et al. Late radiation effects to the rectum and bladder in gynaecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems. Int J Radiat Oncol Biol Phys 2001, 50(5):1101-1112.
10. Barker C.L., Routledge J.A., Farnell D.J.J., et al. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. Br J Cancer 2009, 100(10):1558-1565.
11. Farnell D., Routledge J., Hannon R., et al. Efficacy of data capture for patient reported toxicity following radiotherapy treatment for prostate or cervical cancer. Eur J Cancer 2009, 46(3):534-540.
12. Barraclough L.H., Routledge J.A., Farnell D.J.J., et al. Prospective analysis of patient reported late toxicity following pelvic radiotherapy for gynaecological cancer. Radiother Oncol 2012, 103:327-352.
13. LENT SOMA tables. Radiother Oncol 1995, 35(1):17-60.
14. Aaronson N., Ahmedzal S., Bergman B., et al. The European Organisation for Research and Treatment of Cancer EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. JNatl Cancer Inst 1993, 85:365-376.
15. Fayers P., Aaronson N., Bjordal K., et al. The EORTC QLQ-C30 scoring manual 2001, European Organisation for Research and Treatment of Cancer, Brussels. 3rd ed.
16. Zigmond A., Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
17. Harrison S.E., Watson E.K., Ward A.M., et al. Primary health and supportive care needs of long-term cancer survivors: a questionnaire survey. JClin Oncol 2011, 29(15):2091-2098.
18. Crawford J., Henry J., Crombie C., Taylor E. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 2001, 40:429-434.
19. Gupta P., Sturdee D.W., Palin S.L., et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 2006, 1:49-58.
20. Lind H., Waldenstrom A.C., Dunberger G., et al. Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study. Br J Cancer 2011, 105:737-745.
21. Andreyev J. Gastrointestinal complication of pelvic radiotherapy: are they of any importance?. Gut 2005, 54:1051-1054.
22. Gillespie C., Goode C., Hackett C., Andreyev H.J.N. The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 2007, 26:555-563.
23. Henson C.C., Andreyev H.J., Symonds R.P., Peel D., Swindell R., Davidson S.E. Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists. Clin Oncol 2011, 23(8):552-557.
24. Andreyev H.J.N., Davidson S.E., Gillespie C., Allum W.H., Swarbrick E. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 2012, 61:179-192.
25. Korfage I.J., Essink-Bot M.L., Mols F., et al. Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys 2009, 73:1501-1509.
26. Pilger A., Richter R., Fotopoulou C., et al. Quality of life and sexuality of patients after treatment for gynaecological malignancies: results of a prospective study in 55 patients. Anticancer Res 2012, 32(11):5045-5049.
27. White I.D., Allan H., Faithfull S. Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?. Br J Cancer 2011, 105:903-910.
28. Miles C., Candy B., Jones L., et al. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database of Systematic Reviews 2007, (4). Art. No.: CD005540. http://dx.doi.org/10.1002/14651858.CD005540.pub2.
29. Brotto L., Yule M., Breckon E. Psychological interventions for the sexual sequelae of cancer: a review of the literature. JCancer Surv 2010, 4(4):346-360.
30. Flynn P., Kew F., Kisely S.R. Interventions for psychosexual dysfunction in women treated for gynaecological malignancy. Cochrane Database of Systematic Reviews 2009, (2). Art. No.: CD004708. http://dx.doi.org/10.1002/14651858.CD004708.pub2.